Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
October 10, 2019
American Heart Association President Robert Harrington, M.D., interventional cardiologist and the Arthur L. Bloomfield ...
October 08, 2019
September 30, 2019 โ The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug ...
September 30, 2019
September 30, 2019 โ A biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual ...
September 30, 2019
September 30, 2019 โ Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy ...
September 30, 2019
September 26, 2019 โ New data from the Phase IV independent TWILIGHT trial showed Brilinta (ticagrelor) monotherapy redu ...
September 26, 2019
September 20, 2019 โ Low-dose aspirin does not prolong disability-free survival of healthy people over 70, even in those ...
September 20, 2019
September 18, 2019 โ AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
September 18, 2019
September 11, 2019 โ The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...
September 11, 2019
September 10,2019 โ The combination of ticagrelor and aspirin reduces ischemic events compared with aspirin alone in ...
September 10, 2019
September 9, 2019 โ Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary ...
September 09, 2019
September 9, 2019 โ AstraZeneca announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga ...
September 09, 2019
September 9, 2019 โ The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart ...
September 09, 2019
September 4, 2019 โ Novartis announced results from two new clinical trials evaluating improvement in heart structure ...
September 04, 2019
August 27, 2019 โ Imagine there were a drug that you could take soon after a heart attack that could reduce damage by ...
August 27, 2019ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now